YMI

YM BIOSCIENCES INC. - Notice of YM Biosciences Annual and Special Meeting - 11/18 - 01:26 AM ET

YM BIOSCIENCES INC. - YM BIOSCIENCES - INTENTION - ARBITRATION - 11/17 - 02:13 AM ET

YM BIOSCIENCES INC. - YM BIOSCIENCES RESPONDS TO BBM ANNOUNCEMENT - 11/14 - 06:30 AM ET

BRIEF-YM BioSciences responds to BBM offer - 11/13 - 01:59 PM ET

YM BIOSCIENCES INC. - 1st Quarter Results - 11/12 - 06:28 AM ET

YMI: To Present At BIO Investor Conference @ 17:15 ET [delayed] - 10/30 - 03:53 PM ET

YMI: To Present At BioContact Quebec Conference @ 16:00 ET [delayed] - 10/01 - 02:22 PM ET

YM BIOSCIENCES INC. - YM BIOSCIENCES REPORTS FISCAL YEAR END 2008 - 09/22 - 02:10 AM ET

YM BIOSCIENCES INC. - Statement re Staffing Changes - 08/05 - 02:01 PM ET

YM BIOSCIENCES INC. - YM BioSciences Inc. conference call - 08/05 - 01:59 PM ET

YMI: Conference call regarding Ph II Data for Nimotuzumab in Metastatic Colorectal Cancer @ 12:00 ET Today [delayed] - 08/05 - 11:28 AM ET

YM BIOSCIENCES INC. - YM BIOSCIENCES REPORTS PHASE II DATA FOR NIMOTUZUMAB - 08/05 - 02:35 AM ET

YM BIOSCIENCES INC. - Presents Data at Conference - 07/22 - 05:17 AM ET

FDA lifts clinical hold on YM BioSciences's pain drug - 06/20 - 09:53 AM ET

YMI: Clinical Hold of AeroLEF(R) Lifted by FDA - 06/20 - 07:51 AM ET

YM Biosciences says FDA lifts clinical hold on AeroLEF, clears phase II trial - 06/20 - 02:10 AM ET

YM BIOSCIENCES INC. - YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD - 06/20 - 02:10 AM ET

YM BIOSCIENCES ANNOUNCES FDA LIFTS CLINICAL HOLD ON AEROLEF(R) AND CLEARANCE OF A PHASE II CLINICAL TRIAL - 06/19 - 05:00 PM ET

NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO ANNUAL MEETING - 06/03 - 01:57 PM ET

YM BIOSCIENCES INC. - NIMOTUZUMAB CLINICAL DATA PRESENTED AT ASCO MEETING - 06/02 - 01:51 PM ET

Page 1 of 2     1  2      Previous  |  Next

<< Back to Stock Index